derinet® Switzerland
Back

14.30% (9.50% p.a.) Barrier Reverse Convertible on AbbVie Inc, Eli Lilly, UnitedHealth

  • Valor 112466014
  • ISIN CH1124660148
  • Symbol RMB83V
sustainable
Bid (indicative)%
Nominal
Ask (indicative)%
Nominal
CurrencyUSD
Price on
Sell
Buy
  • sustainable
Eli Lilly & Co.USD 
UnitedHealth Group Inc.USD 
AbbVie IncUSD 
Please note that this is an indication.

Documents

Key data
Yield max.24.70%
Yield max. p.a.18.00%
Riskbuffer19.99%
Interest
Coupon (Coupon p.a.)14.3028% (9.50%)
Accrued interest1.08%
Premium component13.8928%
Interest share0.41%
Day count convention30/360
Pricingclean
Life cycle
Initial fixing06/08/2021
First Trading Day10/08/2021
Payment date11/08/2021
Final fixing06/02/2023
Redemption13/02/2023
Barrier reachedno

Current price information

Intraday1 week1 monthSince emission
until
Product Underlying

Loading data

Performance
UnderlyingClosing PriceStrike PriceBarrier
USD 107.15USD 114.45USD 80.12
USD 230.17USD 263.44USD 184.41
USD 412.34USD 415.12USD 290.58

No chart available

Key data
Yield max.24.70%
Yield max. p.a.18.00%
Riskbuffer19.99%
Interest
Coupon (Coupon p.a.)14.3028% (9.50%)
Accrued interest1.08%
Premium component13.8928%
Interest share0.41%
Day count convention30/360
Pricingclean
Life cycle
Initial fixing06/08/2021
First Trading Day10/08/2021
Payment date11/08/2021
Final fixing06/02/2023
Redemption13/02/2023
Barrier reachedno
Figures
SSPA categorisationBarriere Reverse Convertible
Nominal valueUSD 1,000.00
Reference currencyUSD
QuantoNo
Strike price

Reference price of the underlying used to calculate the cash settlement on expiry of the warrant. In cases of physical delivery it is the price at which the underlying is bought (call) or sold (put). Also called: exercise price

100.00%
Barrier70.00%
Barrier observationcontinuous
ListingSIX Structured Products Exchange
Additional conditions
IssuerVontobel Financial Products Ltd., DIFC Dubai
GuarantorVontobel Holding AG, Zurich
Lead ManagerBank Vontobel AG, Zurich
Redemption / deliveryphysical delivery
Issuance ProgrammeLink to the Issuance Program